AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
Vildagliptin 50.000 Mg ;
14 registrations across 1 African market— 14 active
Markets with Vildagliptin 50.000 Mg ;
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Vilgat Tablets | 🇪🇬Egypt | Tabuk Pharmaceutical Manufacturing Co.Egypt - local under construction | active | — |
| Grasp Film Coated Tablets | 🇪🇬Egypt | Egyphar | active | — |
| Dibavally® Tablets | 🇪🇬Egypt | AUG Pharma | active | — |
| Vildaglip Tablets | 🇪🇬Egypt | so value pharma | active | — |
| GLUVILDAN Tablets | 🇪🇬Egypt | islamic company for pharmaceuticals,chemicals and medical appliances (pharco pharmaceuticals | active | — |
| Icandra Tablets | 🇪🇬Egypt | Bio Med For Pharmaceutical Industries (BIOMED) | active | — |
| Dibavally® Tablets | 🇪🇬Egypt | AUG Pharma | active | — |
| Vildaglip Tablets | 🇪🇬Egypt | so value pharma | active | — |
| Grasp Film Coated Tablets | 🇪🇬Egypt | Egyphar | active | — |
| Vilgat Tablets | 🇪🇬Egypt | Tabuk Pharmaceutical Manufacturing Co.Egypt - local under construction | active | — |
| GLUVILDAN Tablets | 🇪🇬Egypt | islamic company for pharmaceuticals,chemicals and medical appliances (pharco pharmaceuticals | active | — |
| Icandra Tablets | 🇪🇬Egypt | Bio Med For Pharmaceutical Industries (BIOMED) | active | — |
| Vildagluse Tablets | 🇪🇬Egypt | Inspire Pharmaceutical Company IPC Pharma | active | — |
| Vildagluse Tablets | 🇪🇬Egypt | Inspire Pharmaceutical Company IPC Pharma | active | — |
Vildagliptin 50.000 Mg ; in Africa — Regulatory Overview
Vildagliptin 50.000 Mg ; is registered across 1 African markets with 14 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Egypt. AfricaRegulatory refreshes this data daily from official government sources.
Of the 14 registrations, 14 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.